Role of NF-κB as a Prognostic Marker in Breast Cancer : A Pilot Study in Indian Patients
Authors:
- 25 April 2013
- journal article
- research article
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 4 (3) , 242-247
Abstract
The nuclear factor κB (NF-κB) is a superfamily of transcription factors. It plays an important role in development & progression of cancer. This study was conducted in a tertiary care centre to investigate the significance of NF-κB as a prognostic marker in breast cancer and study its relation with established prognostic markers such as tumor grade, lymph node status, hormone receptor & HER-2/neu expression. We measured NF-κB expression of breast cancer tissue as a test sample & from fibroadenoma as a control. Measurement was done by Western Blot Technique using p65 protein of NF-κB super family of transcription factors. ER,PR and HER-2/neu were measured by immunohistochemistry methods. NF-κB/p65 is significantly associated with large tumor size (≥5 cm), high grade tumors, negative ER, negative PR, positive HER-2/neu and high NPI (≥5.4) scores. NF-κB/p65 expression implies aggressive biological behaviour of breast cancer & this study validates significant association of NF-κB /p65 overexpression with large tumor size, negative estrogen & progesterone receptor status and overexpression of c-erbB2 oncoprotein.Keywords
This publication has 17 references indexed in Scilit:
- NF-κB, stem cells and breast cancer: the links get strongerBreast Cancer Research, 2011
- Nuclear Factor-κB Activation: From Bench to BedsideExperimental Biology and Medicine, 2008
- NF-κB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivationBritish Journal of Cancer, 2007
- Pro-apoptotic role of NF-κB: Implications for cancer therapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2006
- Activation of nuclear factor-κB (NFκB) identifies a high-risk subset of hormone-dependent breast cancersThe International Journal of Biochemistry & Cell Biology, 2005
- The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwanese patients with breast cancerClinica Chimica Acta, 2003
- Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation.2003
- The nuclear factor kappa B (NF-κB): A potential therapeutic target for estrogen receptor negative breast cancersProceedings of the National Academy of Sciences, 2001
- Epidermal growth factor-induced nuclear factor κB activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cellsProceedings of the National Academy of Sciences, 2000
- Negative Interaction between the RelA(p65) Subunit of NF-κB and the Progesterone ReceptorJournal of Biological Chemistry, 1996